Skip to main content

Table 2 SPARCC and SSS values at baseline and 3-month follow-up in 58 patients

From: Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system

 

Total axSpA

nr-axSpA(n = 29)

AS(n = 29)

P-value

SPARCC

 Baseline

24.79 ± 17.13

22.90 ± 15.23

26.69 ± 18.91

0.602

 3-month

7.74 ± 9.18**

6.91 ± 7.04**

8.57 ± 10.99**

0.755

Fat metaplasia

 Baseline

14.89 ± 12.14

8.36 ± 9.82

21.41 ± 10.75

< 0.001

 3-month

21.09 ± 11.81**

14.02 ± 9.20*

28.17 ± 9.78*

< 0.001

Erosion

 Baseline

9.58 ± 8.53

5.69 ± 4.73

13.47 ± 9.72

0.001

 3-month

4.65 ± 4.88**

3.19 ± 3.05*

6.10 ± 5.90**

0.061

Backfill

 Baseline

2.47 ± 4.13

0.21 ± 0.63

4.72 ± 4.87

< 0.001

 3-month

3.78 ± 5.11**

1.10 ± 2.05*

6.47 ± 5.83

< 0.001

  1. Comparison of baseline and 3-month follow-up, **: P < 0.001 *: P < 0.05